Skip to Content
Skip to Local Navigation
Skip to Global Navigation
Explore Stanford Medicine
Find a doctor
Pediatrician or pediatric specialist
Clinics & Services
Basic science departments
Clinical science departments
See full directory
Clinical research fellows
Continuing Medical Education
Residencies & fellowships
High School & Undergraduate Programs
Basic science departments
Clinical science departments
Support teaching, research, and patient care.
Ways to give
Why giving matters
Make a gift online
Maps & directions
How you can help
Submit Search Query
Clinical Associate Professor, Medicine - Oncology
Cancer > Hematology
Cancer > Lymphoma
Clinical Associate Professor,
Medicine - Oncology
Medical Education: Stanford University School of Medicine (2006) CA
Fellowship: Stanford University Hematology and Oncology Fellowship (2012) CA
Residency: Stanford University Internal Medicine Residency (2011) CA
Board Certification: American Board of Internal Medicine, Medical Oncology (2012)
Tel: (650) 498-6000
Stanford Cancer Center
875 Blake Wilbur Dr Rm CC2325
Stanford CA 94305
Tel: (650) 498-6000
Fax: (650) 498-5030
Get a Second Opinion
10 Results / Page
Profiles With Related Publications
Saul A. Rosenberg, MD, Professor of Lymphoma
Cancer > Lymphoma, Burkitt's Lymphoma, Hodgkin's Disease, Investigational Therapeutics, Lymphoma , Mycosis Fungoides, Non-Hodgkin's Lymphoma, Oncology (Cancer), Plasmacytoma, Waldenstrom's Macroglobulinemia , Medical Oncology
Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.
Ash A. Alizadeh, MD/PhD
Moghadam Family Professor
Cancer > Lymphoma, Lymphoma, B-Cell Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Burkitt Lymphoma, Follicular Lymphoma, Diffuse Large-Cell Lymphomas, Leukemia, Hairy Cell, Lymphoma, B-Cell, Marginal Zone, Hodgkin Disease, Medical Oncology
My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.
Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital, Emeritus
Bone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia.
A. Dimitrios Colevas, MD
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Cancer > Head and Neck Cancer, Oncology (Cancer), developmental therapeutics, investigational new drugs, Adverse event( toxicity) evaluation and reporting, Thyroid Cancer, combined chemotherapy and radiation treatment, Medical Oncology
Multi- modality treatment of Head and Neck Cancer
Phase 1 clinical trials
Sarah S. Donaldson, MD
Catharine and Howard Avery Professor in the School of Medicine, Emerita
Combined Modality Treatment of Cancer
Late Effects of Treatment
Genetic Effects of Cancer
Pediatric Radiation Oncolgy
Radiotherapy for Benign Diseases
Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics
Cancer > GI Oncology, Cancer Genetics, Gastrointestinal Cancers - Genetics, Gastrointestinal Cancers - Medical Oncology, Breast Cancer - Genetics, Ovarian Cancer - Genetics, Medical Oncology, Molecular Tumor Board
Mammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNAdamage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.
Kristen N Ganjoo
Professor of Medicine (Oncology)
Cancer > Sarcoma, Soft Tissue Sarcoma, Gastrointestinal Stromal Tumors, Ewing's Sarcoma, Osteosarcoma, Medical Oncology, Uterine leiomyosarcoma, Leiomyosarcoma, Liposarcoma, Synovial sarcoma
Giant cell tumor of the bone
Gastrointestinal stromal tumors
Soft tissue sarcoma
Assistant Professor (Research) of Pathology, of Medicine (BMIR) and, by courtesy, of Biomedical Data Science
Computational systems biology of human disease. Particular focus on integration of high-throughput datasets with each other, and with phenotypic information and clinical outcomes.
Associate Professor of Radiation Oncology (Radiation Physics) and, by courtesy, of Radiology (Molecular Imaging Program at Stanford)
Applications of molecular imaging in radiation therapy, development of hypoxia and radiosensitivity imaging techniques, small animal image-guided conformal radiotherapy, image processing and analysis.
Philip C. Hanawalt
Dr. Morris Herzstein Professor in Biology, Emeritus
My current interest includes two principal areas:
1. The molecular basis for diseases in which the pathway of transcription-coupled DNA repair is defective, including Cockyne syndrome (CS) and UV-sensitive syndrome (UVSS). Patients are severely sensitive to sunlight but get no cancers. See Hanawalt & Spivak, 2008, for review.
2. Transcription arrest by guanine-rich DNA sequences and non-canonical secondary structures. Transcription collisions with replication forks.
Steven Hancock, MD
Professor of Radiation Oncology (Radiation Therapy), Emeritus
Cancer > Cutaneous (Dermatologic) Oncology, Cancer > Radiation Oncology, Cancer > Urologic Oncology, CNS Cancers, Prostate Cancer, Bladder cancer, Kidney Cancer, Lymphomas, Radiation Therapy, Radiation Injuries, Stereotactic Radiosurgery, Stereotactic Ablative Body Radiotherapy, Acoustic Neuroma, Meningioma, Radiation Oncology
Outcomes of radiation treatment for prostate cancer. Clinical research interests in the late effects of radiation on normal tissues and chemical modification of radiation injury. Hodgkins's disease and late effects of radiation and combined modality therapy. Radiation sensitizers. Hypoxic cell cytotoxins. Esophageal cancers.
General adult and pediatric radiation therapy.
Henry S. Kaplan-Harry Lebeson Professor of Cancer Biology
Cancer > Lymphoma, Cancer > Radiation Oncology, Lymphoma , Cutaneous Lymphoma , Cutaneous Lymphoma - Radiation Oncology, Hodgkin's Disease - Radiation Oncology, Non-Hodgkin's Lymphoma - Radiation Oncology, Mycosis Fungoides - Radiation Oncology, Burkitt's Lymphoma - Radiation Oncology, Burkitt's Lymphoma, Leukemia, Leukemia - Radiation Oncology, Plasmacytoma, Plasmacytoma - Radiation Oncology, Radiation Oncology
Irradiation immunosuppression; total body irradiation;, psychosocial effects of cancer treatment; treatment of lymphoma;, mycosis fungoides.
Publication Topics For This Person
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
DNA-Directed RNA Polymerases
Predictive Value of Tests
RNA Polymerase II